Table 2.
Compound | Heart | Liver | Spleen | Lung | Kidneys | |
---|---|---|---|---|---|---|
Saline | H | 0.602 ± 0.134 | 4.536 ± 0.632 | 0.333 ± 0.063 | 0.657 ± 0.105 | 1.333 ± 0.134 |
L | 0.594 ± 0.051 | 5.038 ± 0.534 | 0.368 ± 0.075 | 0.720 ± 0.121 | 1.689 ± 0.271 | |
Blank HCO-SLN | H | 0.583 ± 0.070 | 5.063 ± 0.453b | 0.447 ± 0.124b | 0.626 ± 0.109 | 1.364 ± 0.214 |
L | 0.642 ± 0.067 | 4.787 ± 0.813 | 0.426 ± 0.045 | 0.732 ± 0.161 | 1.661 ± 0.420 | |
Til-HCO-SLN | H | 0.477 ± 0.076a | 5.072 ± 0.493a | 0.425 ± 0.100a | 0.629 ± 0.147 | 1.305 ± 0.226 |
L | 0.618 ± 0.076 | 4.405 ± 0.877 | 0.395 ± 0.075 | 0.732 ± 0.119 | 1.659 ± 0.222 | |
Native Tilmicosin | L | 0.662 ± 0.030 | 4.740 ± 0.600 | 0.359 ± 0.076 | 0.707 ± 0.078 | 1.548 ± 0.192 |
a Significant difference between Til-HCO-SLN and saline treated mice, p < 0.05.
b Significant difference between blank HCO-SLN and saline treated mice, p < 0.05.
H: high dose; L: low dose.